Zentiva Group, a.s.

Zentiva Group, a.s. is a pharmaceutical company based in Prague, Czech Republic, specializing in the development, manufacturing, and distribution of generic medicines and consumer healthcare products. The company supplies high-quality, affordable prescription and over-the-counter pharmaceuticals to more than 100 million people across over 40 countries in Europe and international markets. Zentiva operates four primary manufacturing facilities alongside an extensive network of external contract manufacturing partners to ensure robust supply chain security. Its diverse product portfolio covers key therapeutic areas including cardiovascular disease, oncology, central nervous system disorders, respiratory health, diabetes, and consumer healthcare solutions. In addition to finished dosage drug production, Zentiva provides active pharmaceutical ingredient supply, contract development, out-licensing, and custom manufacturing services to pharmaceutical partners worldwide. Through recent strategic acquisitions and bioequivalent innovation, the company continues to expand into biologics and biosimilars to increase healthcare accessibility. Employing more than 5,400 people, Zentiva maintains high quality standards and rigorous pharmacovigilance across its European operations.